Skip to main content
. 2022 Feb 22;9:722058. doi: 10.3389/fmed.2022.722058

Table 2.

Details of mTOR inhibitor and tacrolimus use.

Sirolimus based regimen Everolimus based regimen Tacrolimus based regimen
No. of subjects 9 2 15
Mean daily dose (mg) 1.72 1 4.3
Mean trough level (ng/mL) 8.46 2.2 5.8